Question 29

The restricted drug distribution program iPLEDGE is for the medication Isotretinoin.

iPLEDGE is specifically designed to manage the distribution of Isotretinoin, a powerful medication used to treat severe acne, due to the significant risks associated with its use, particularly the potential for severe birth defects.

A) Dofetilide

Dofetilide is an antiarrhythmic medication used to treat irregular heartbeats, but it is not subject to the iPLEDGE program. This medication has its own set of safety protocols but does not involve the restrictions that iPLEDGE enforces.

B) Thalidomide

Thalidomide is indeed associated with severe risks, such as birth defects, and has its own restricted distribution program called STEPS. However, it is not part of the iPLEDGE program, which is specifically for Isotretinoin.

C) Clozapine

Clozapine is an antipsychotic medication that requires monitoring due to the risk of agranulocytosis (a potentially life-threatening decrease in white blood cells), but it is not managed under the iPLEDGE program. Instead, its distribution is controlled through a different risk management program.

D) Isotretinoin

Isotretinoin is the only medication listed that falls under the iPLEDGE program. This program was established to prevent fetal exposure to the drug due to its high teratogenic risk, making it essential for patients to follow strict guidelines during treatment.

Conclusion

Isotretinoin is definitively the correct answer as it is the only medication among the options listed that is governed by the iPLEDGE program. All other options, while they may have their own safety protocols, do not fall under this specific restricted distribution framework, highlighting the unique risk management needs associated with Isotretinoin.